1Bingefors K,Pashos CL,Smith MD,Berger ML.Health Care Cost,Quality,and Outcomes:ISPOR Book of Terms.Lawrenceville,NJ:International Society for Pharmacoeconomics & Outcomes Research.2003.
2Institute of Medicine.Assessing Medical Technologies.Washington,DC:National Academy Press.1985.
3National Coordinating Centre for HTA.Annual Report of the NHS Health Technology Assessment Programme 1998.London:Department of Health,1998.
4Kunkle GC.New challenge or the past revisited:the office of technology assessment in historical context.Technol Soc,1995,17:175-196.
5Kaiser Family Foundation.Health care costs:a primer[O/L].[2008-05-04].http://www.kff.org.
6Neumann PJ,Divi N,Beinfeld MT,et al.Medicare's national coverage decisions,1999 2003:quality of evidence and review times.Health Aff,2005,24:243-254.
7Neumann PJ,Rosen AB,Weinstein MC.Medicare and costeffectiveness analysis.New Eng1 J Med,2005,353:1516-1522.
8Gibson M,Santa J.The drug effectiveness review project:an important step forward.Health Aff,2006,26:W272-275.
9Neumann PJ.Emerging lessons from the drug effectiveness review project.Health Aff,2006,25:W262-271.
10Steinberg EP,Luce BR.Evidence-based? Caveat emptor! Health Aff,2005,24:80-92.
